Homology Medicines adds Cam Wheeler and Mahendra Shah to Board along with $83.5m Series-B financing led by Deerfield Management
– USA, MA – Homology Medicines, Inc., a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients, announced today the closing of an $83.5 million Series B financing led by Deerfield Management.…